A collaborative team of researchers from Harvard University, Columbia University and Rutgers University has unlocked the mechanism of the danger signal adenosine triphosphate (ATP). The discovery could go on to influence the way in which immunomodulators, such as vaccines and allergy medications, are formulated.

The European Medicines Agency on Thursday identified severe allergic reactions as potential side effects of Novavax Inc.’s COVID-19 vaccine.